Drug Shortage Report for TEVA-CEPHALEXIN 250
| Report ID | 200864 |
| Drug Identification Number | 00342092 |
| Brand name | TEVA-CEPHALEXIN 250 |
| Common or Proper name | TEVA-CEPHALEXIN 250 |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEPHALEXIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 150ML |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-03 |
| Estimated end date | 2024-04-30 |
| Actual end date | 2024-04-24 |
| Shortage status | Resolved |
| Updated date | 2024-04-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v35 | 2024-04-25 | French | Compare |
| v34 | 2024-04-25 | English | Compare |
| v33 | 2024-04-18 | French | Compare |
| v32 | 2024-04-18 | English | Compare |
| v31 | 2024-04-11 | French | Compare |
| v30 | 2024-04-11 | English | Compare |
| v29 | 2024-04-05 | French | Compare |
| v28 | 2024-04-05 | English | Compare |
| v27 | 2024-03-14 | French | Compare |
| v26 | 2024-03-14 | English | Compare |
| v25 | 2024-02-15 | French | Compare |
| v24 | 2024-02-15 | English | Compare |
| v23 | 2024-01-11 | French | Compare |
| v22 | 2024-01-11 | English | Compare |
| v21 | 2024-01-11 | French | Compare |
| v20 | 2024-01-11 | English | Compare |
| v19 | 2023-11-30 | French | Compare |
| v18 | 2023-11-30 | English | Compare |
| v17 | 2023-10-19 | French | Compare |
| v16 | 2023-10-19 | English | Compare |